Product NDC: | 51672-1348 |
Proprietary Name: | Escitalopram Oxalate |
Non Proprietary Name: | Escitalopram Oxalate |
Active Ingredient(s): | 5 mg/5mL & nbsp; Escitalopram Oxalate |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-1348 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079121 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120503 |
Package NDC: | 51672-1348-9 |
Package Description: | 1 BOTTLE in 1 CARTON (51672-1348-9) > 480 mL in 1 BOTTLE |
NDC Code | 51672-1348-9 |
Proprietary Name | Escitalopram Oxalate |
Package Description | 1 BOTTLE in 1 CARTON (51672-1348-9) > 480 mL in 1 BOTTLE |
Product NDC | 51672-1348 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Escitalopram Oxalate |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20120503 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | ESCITALOPRAM OXALATE |
Strength Number | 5 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |